Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.

• 資料種別: 博士論文
• タイトル: Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.
• 著者・編者: Nishiguchi, Yukiko; Fujiwara-Tani, Rina; Sasaki, Takamitsu; Luo, Yi; Ohmori, Hitoshi; Kishi, Shingo; Mori, Shiori; Goto, Kei; Yasui, Wataru; Sho, Masayuki; Kuniyasu, Hiroki
• 著者標目: Nishiguchi, Yukiko; Fujiwara-Tani, Rina; Sasaki, Takamitsu; Luo, Yi; Ohmori, Hitoshi; Kishi, Shingo; Mori, Shiori; Goto, Kei; Yasui, Wataru; Sho, Masayuki; Kuniyasu, Hiroki
• 出版事項: Impact Journals, LLC
• 出版年月日等: 2019-03-15
• 出版年（W3CDTF）: 2019-03-15
• 並列タイトル等: 胃癌におけるクローディン4標的化によるシスプラチン化学療法感受性の向上
• タイトル（掲載誌）: Oncotarget
• 巻号年月日等（掲載誌）: 10 22
• 掲載巻: 10
• 掲載号: 22
• 掲載ページ: 2189-2202
• ISSN（掲載誌）: ISSN : 1949-2553
• 授与機関名: 奈良県立医科大学
• 授与年月日: 2019-06-26
• 報告番号: 甲第713号
• 学位: 博士（医学）
• 本文の言語コード: eng
• 件名標目: claudin; tight junction
• 対象利用者: 一般
• 一般注記: type:Thesis; Claudins are major tight-junction proteins that mediate cellular polarity and differentiation. The present study investigated whether the 4D3 antibody to the human CLDN4 extracellular domain (that we previously established) is capable of modulating chemotherapeutic sensitivity in gastric cancer (GC). The results of the present study showed that CLDN4 was overexpressed in 137 of the 192 analyzed GC cases, and that CLDN4 expression was retained in tumors of a lower histological grade (more differentiated), and/or those that were caudal-type homeobox protein 2 (CDX2)-positive, but was reduced in more highly undifferentiated, and CDX2-negative GC cases. The study also compared the synergic effects of combining 4D3 with CDDP treatment and knocking down CLDN4 expression in MKN74 and TMK-1 human GC cells. Co-treatment with 4D3 increased anti-tumor effects of CDDP, whereas CLDN4 knockdown did not. In the TMK-1 cells, non-tight junction CLDN4 associated with integrin β1, increasing stem cell-associated proteins via FAK-c-SRC signals. The anti-tumoral effect of CDDP and 4D3 was examined in a nude mouse subcutaneous tumor model. In the two GC cell lines, concurrent treatment with 4D3 and CDDP synergistically inhibited cell proliferation and increased tumor necrosis and apoptosis to a greater degree than CDDP treatment alone. These findings suggest that 4D3 might increase chemotherapeutic sensitivity by evoking structural disintegration of tight-junction CLDN4 expressed in gastric cancer.; 博士（医学）・甲第713号・令和元年6月26日; Copyright: Nishiguchi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0 https://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.; identifier:Oncotarget Vol.10 No.22 p.2189-2202 (2019 Mar); identifier:19492553; identifier:http://ginmu.naramed-u.ac.jp/dspace/handle/10564/3585; identifier:Oncotarget, 10(22): 2189-2202
• オンライン閲覧公開範囲: インターネット公開
• 関連情報（DOI）: 10.18632/oncotarget.26758
• 連携機関・データベース: 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• 提供元機関・データベース: 奈良県立医科大学 : 奈良県立医科大学機関リポジトリ GINMU

目次

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3585/1/01%e7%94%b2713%e6%9c%ac%e6%96%87%e3%81%ae%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3585/2/02%e7%94%b2713%e5%af%a9%e6%9f%bb%e8%a6%81%e6%97%a8.pdf fulltext

http://ginmu.naramed-u.ac.jp/dspace/bitstream/10564/3585/3/03%e7%94%b2713%e6%9c%ac%e6%96%87.pdf fulltext